Triptorelin (GnRH)

Triptorelin Acetate
MW:1311.45
MF:C64H82N18O13
HS Code:3002200000
Packing:200kgs/Drum
CAS: 57773-63-4/140194-24-7
Category : Inorganic chemicals
Assay: 98% min.
Appearance: white or off-white crystalline powder
Standard:enterprise standard
Brandname: Nan Jian,He Zhong
Origin :Wuhan, China
Payments: T/T,West Union,Money Gram,etc
Qualitification: ISO 9001, KOSHER,UKAS
Delivery time: send within 24 hours after we check your payments,usually reach U within a week
Min order: 10g
Product Warranty :3 years
Price: change according to the market fluctuations, pls ask the price before purchase!
Top quality products with the most competitive rate. Free samples are available.
Description:
Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl (Ipsen) and Diphereline and Gonapeptyl (Ferring Pharmaceuticals). In the United States, it is sold by Watson as Trelstar.In Iran Triptorelin is marketed under the brand name Variopeptyl (Varian Darou Pajooh). In India, Dr. Reddy's Laboratories has launched recently Triptorelin under the brand name 'Pamorelin LA'. During the treatment of prostate cancer it does cause a surge of testosterone (an initial uplevel of testosterone levels), known as a flare effect. In men a reduction of serum testosterone levels into the range normally seen after surgical castration occurs approximately two to four weeks after initiation of therapy. Systematic IUPAC Name: [d-Trp6]GnRH [edit]References Lahlou N, Carel JC, Chaussain JL, Roger M (July 2000). 'Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics'. J Pediatr Endocrinol Metab 13 Suppl 1: 723â€'37. PMID 10969915. Padula AM (August 2005). 'GnRH analoguesâ€'agonists and antagonists'. Anim Reprod Sci 88 (1â€'2): 115â€'26. doi:10.1016/j.anireprosci.2005.05.005. PMID 15955640.€"2): 115â€"26. doi:10.1016/j.anireprosci.2005.05.005. PMID 15955640.c;€"26. doi:10.1016/j.anireprosci.2005.05.005. PMID 15955640.
FOR RESEARCH PURPOSES ONLY

Triptorelin raises testosterone levels by causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.